JPH0152054B2 - - Google Patents
Info
- Publication number
- JPH0152054B2 JPH0152054B2 JP56107891A JP10789181A JPH0152054B2 JP H0152054 B2 JPH0152054 B2 JP H0152054B2 JP 56107891 A JP56107891 A JP 56107891A JP 10789181 A JP10789181 A JP 10789181A JP H0152054 B2 JPH0152054 B2 JP H0152054B2
- Authority
- JP
- Japan
- Prior art keywords
- oxygen
- group
- complex
- iron
- hydrophobic polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 46
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 32
- 239000001301 oxygen Substances 0.000 claims description 32
- 229910052760 oxygen Inorganic materials 0.000 claims description 32
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 20
- -1 O-methyldextran Polymers 0.000 claims description 19
- 229910052742 iron Inorganic materials 0.000 claims description 16
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 13
- 150000004032 porphyrins Chemical class 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 8
- 229920002223 polystyrene Polymers 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 239000003463 adsorbent Substances 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229920002643 polyglutamic acid Polymers 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000004743 Polypropylene Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 6
- 150000002460 imidazoles Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- GIWQSPITLQVMSG-UHFFFAOYSA-N 1,2-dimethylimidazole Chemical compound CC1=NC=CN1C GIWQSPITLQVMSG-UHFFFAOYSA-N 0.000 description 3
- IQWYMGYULZCICZ-UHFFFAOYSA-N 2-methyl-1-tritylimidazole Chemical compound CC1=NC=CN1C(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 IQWYMGYULZCICZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000002336 sorption--desorption measurement Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 150000002505 iron Chemical class 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical compound N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 1
- SFCVVDTZXSZBHB-UHFFFAOYSA-M 1-dodecylpyrimidin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CN=C1 SFCVVDTZXSZBHB-UHFFFAOYSA-M 0.000 description 1
- NYYVCPHBKQYINK-UHFFFAOYSA-N 1-ethyl-2-methylimidazole Chemical compound CCN1C=CN=C1C NYYVCPHBKQYINK-UHFFFAOYSA-N 0.000 description 1
- RHZSMKFEFKUPGR-UHFFFAOYSA-N 2-methyl-1h-imidazole;silver Chemical compound [Ag].CC1=NC=CN1 RHZSMKFEFKUPGR-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- TVSPOLBJUVJVCV-UHFFFAOYSA-N benzene;heptane Chemical compound C1=CC=CC=C1.CCCCCCC TVSPOLBJUVJVCV-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- QPJDMGCKMHUXFD-UHFFFAOYSA-N cyanogen chloride Chemical compound ClC#N QPJDMGCKMHUXFD-UHFFFAOYSA-N 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- QLDBEJYOMKCBID-CKUXDGONSA-L disodium;(2s)-2-(dodecylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCN[C@H](C([O-])=O)CCC([O-])=O QLDBEJYOMKCBID-CKUXDGONSA-L 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 150000004698 iron complex Chemical class 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 108010039177 polyphenylalanine Proteins 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- CUXKZYSCZCNPNX-UHFFFAOYSA-N tetradecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCCCC[NH3+] CUXKZYSCZCNPNX-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Gas Separation By Absorption (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
【発明の詳細な説明】
この発明はいわゆる鉄()ポルフイリン錯体
を埋め込んだ疎水性高分子粒子からなる酸素吸脱
着剤に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an oxygen adsorbing/desorbing agent comprising hydrophobic polymer particles embedded with so-called iron()porphyrin complexes.
ヘモグロビンやミオグロビンの鉄()ポルフ
イリン錯体は酸素分子を可逆的に吸脱着する。こ
のような天然のポリフイリン鉄()錯体と類似
の酸素吸脱着機能を持つ錯体を合成するために、
従来、多くの研究が発表されている。その例とし
ては、J.P.Collman,Accounts of Chemical
Research 10 265(1977);F.Basolo,B.M.
HoffmanおよびJ.A.Jbers,ibid.,8 384
(1975);Tsuchida,Hasegawaおよび
Kanayama Macromolecules1978,11,947―
955などである。特に、室温条件下で酸素錯体が
生成できると報告されているポリフイリン鉄
()錯体として鉄()―5,10,15,20―テ
トラ〔α,α,α,α―(O―ピパラミドフエニ
ル)〕ポルフイリン錯体(J.P.Collman他、
Journal of American Chemical Society97
1427(1975)参照)がある。しかし、この錯体は
少量でも水が共存すると、直ぐに酸化されるた
め、酸素錯体を生成できなくなるのである。この
ため室温で、水が共存していても酸素錯体を与え
る鉄()ポルフイリン錯体の開発が継続して推
進されている。 Iron ()porphyrin complexes in hemoglobin and myoglobin reversibly adsorb and desorb oxygen molecules. In order to synthesize a complex with an oxygen adsorption/desorption function similar to such a natural polyphyrin iron () complex,
Many studies have been published so far. Examples include J.P. Collman, Accounts of Chemical
Research 10 265 (1977); F. Basolo, B.M.
Hoffman and JAJbers, ibid., 8 384
(1975); Tsuchida, Hasegawa and
Kanayama Macromolecules 1978, 11, 947―
955 etc. In particular, iron()-5,10,15,20-tetra[α,α,α,α-(O-piparamidofu enyl)] porphyrin complex (JP Collman et al.,
Journal of American Chemical Society 97
1427 (1975)). However, if even a small amount of water coexists with this complex, it will be immediately oxidized, making it impossible to generate an oxygen complex. For this reason, the development of iron()porphyrin complexes that provide oxygen complexes even in the coexistence of water at room temperature is being promoted.
したがつて、この発明の目的は室温下の水相あ
るいは水共存溶媒系で酸素錯体を形成するととも
に、酸素分圧差によつて酸素を可逆的に吸脱着で
きるポルフイリン鉄()錯体系を提供すること
にある。 Therefore, an object of the present invention is to provide a porphyrin iron() complex system that can form an oxygen complex in an aqueous phase or a water-coexisting solvent system at room temperature and can reversibly adsorb and desorb oxygen depending on the oxygen partial pressure difference. There is a particular thing.
この発明によれば、上記の目的は、
(ここで、R1はこれが結合するイミダゾール
基の中心鉄への配位を阻害しない基、R2はアル
キル基トリチル基または置換トリチル基、R3お
よびR4はそれぞれ水素または置換基)で示され
る鉄()5,10,15,20―テトラ〔α,α,
α,α―(O―ピバラミドフエニル)〕ポルフイ
リン(以下、Fe()Tpiv PP)錯体を疎水性高
分子粒子に埋め込んでこれを水系媒質に分散させ
ることによつて達成できる。 According to this invention, the above objectives are: (Here, R 1 is a group that does not inhibit the coordination of the imidazole group to the central iron, R 2 is an alkyl trityl group or a substituted trityl group, and R 3 and R 4 are hydrogen or a substituent, respectively.) Iron () 5, 10, 15, 20-tetra [α, α,
This can be achieved by embedding an α,α-(O-pivalamidophenyl)]porphyrin (hereinafter referred to as Fe()TpivPP) complex into hydrophobic polymer particles and dispersing them in an aqueous medium.
本発明者らは鉄()ポルフイリン錯体を工夫
された疎水場に置くことによつて水が共存した系
でも酸素錯体を形成させ得ると考えた。水に難溶
性のポルフイリンを配位子とした鉄錯体を水中に
おいて疎水場に置くには界面活性剤などのミセル
形成剤を用いることも考えられるが、本発明者ら
はFe()Tpiv PPを疎水性高分子粒子に埋め込
むことによつて、安定な酸素錯体を形成できるこ
とを見い出し、本発明を完成するに至つた。 The present inventors thought that by placing the iron()porphyrin complex in a specially designed hydrophobic field, it is possible to form an oxygen complex even in a system where water coexists. Although it is conceivable to use a micelle forming agent such as a surfactant to place an iron complex with a poorly water-soluble porphyrin as a ligand in a hydrophobic field in water, the present inventors have developed Fe()Tpiv PP. The present inventors have discovered that a stable oxygen complex can be formed by embedding it in hydrophobic polymer particles, and have completed the present invention.
Fe()Tpiv PP錯体は単独では酸素を配位に
より吸脱着する作用はほとんどなく、この目的を
達成するためには軸位に塩基性配位子を配位させ
る必要がある。この発明では、この軸配位子とし
て前記式に示すように、式
で示される置換イミダゾールを用いている。ここ
で、R1は当該イミダゾールのFe()Tpiv PPへ
の配位を阻害しない基であり、メチル基、エチル
基およびプロピル基(n―プロピル基およびイソ
プロピル基を含む)が好ましい。R2はアルキル
基例えばC1〜C30アルキル基またはトリチル基、
置換トリチル基である。R3およびR4は水素また
は任意の置換基である。このような置換イミダゾ
ールの例を挙げると、1,2―ジメチルイミダゾ
ール、1―エチル―2―メチルイミダゾール、1
―n―ラウリル―2―メチルイミダゾール、1―
トリチル―2―メチルイミダゾール等である。軸
配位子としての置換イミダゾールは2位に上記置
換基(R1)を持つことが重要である。2位に置
換基を持つと、該置換イミダゾールはFe Tpiv
PPの中心鉄の第5および第6配位座のうちの一
つに配位し、他の配位座が空の5配位型デオキシ
錯体のみを生成し、この空の配位座に酸素分子を
容易に配位するようになる。しかし、2位に置換
基R1を持たないイミダゾールは上記第5および
第6配位座の両方に配位してしまうため酸素が吸
着できなくなる。 The Fe()Tpiv PP complex alone has almost no effect of adsorbing and desorbing oxygen through coordination, and in order to achieve this purpose, it is necessary to coordinate a basic ligand at the axial position. In this invention, as this axial ligand, as shown in the above formula, The substituted imidazole shown is used. Here, R 1 is a group that does not inhibit the coordination of the imidazole to Fe()Tpiv PP, and is preferably a methyl group, an ethyl group, or a propyl group (including an n-propyl group and an isopropyl group). R 2 is an alkyl group such as a C 1 -C 30 alkyl group or a trityl group,
It is a substituted trityl group. R 3 and R 4 are hydrogen or any substituent. Examples of such substituted imidazoles include 1,2-dimethylimidazole, 1-ethyl-2-methylimidazole, 1
-n-lauryl-2-methylimidazole, 1-
Trityl-2-methylimidazole and the like. It is important that the substituted imidazole as an axial ligand has the above substituent (R 1 ) at the 2-position. When a substituent is present at the 2-position, the substituted imidazole becomes Fe Tpiv
Only a five-coordinated deoxy complex is formed, with the other coordination sites being empty, with oxygen coordinating to one of the 5th and 6th coordination sites of the central iron of PP. It becomes easier to coordinate molecules. However, since imidazole having no substituent R 1 at the 2-position coordinates to both the fifth and sixth coordination sites, oxygen cannot be adsorbed.
上記Fe()Tpiv PP錯体を埋め込む疎水性高
分子の例を挙げるとポリスチレン(好ましい)、
ポリエチレン、ポリプロピレン、ポリ―α―メチ
ルスチレン、O―アルキル(例えばメチル)デキ
ストラン、ポリグルタミン酸の長鎖アルキル(例
えばn―ラウリル)エステル、ポリフエニルアラ
ニン等である。なお、ポリアミド、ポリウレタ
ン、飽和ポリエステル等も使用できる。このよう
な疎水性高分子にFe()Tpiv PPを埋め込むに
は、例えば、不活性雰囲気(例えば、窒素ガス)
中で、Fe()Tpiv PP、過剰量の置換イミダゾ
ールおよび疎水性高分子例えば、Fe Tpiv PP1
グラムにつき10グラム以上)を適当な溶媒例えば
トルエンに溶解し、亜ニチオン酸ナトリウム等の
還元剤でFe Tpiv PPの中心鉄を二価に還元す
る。ついで、溶媒層を分取し、これを脱水した
後、凍結乾燥処理することによつてFe()Tpiv
PP錯体を埋め込んだ疎水性高分子粒子が得られ
る。この粒子の大きさに特に制限はないが、径が
0.2mm以下(普通0.01μ以上)のものが上記手法に
よつて作れる。 Examples of hydrophobic polymers in which the Fe()Tpiv PP complex is embedded include polystyrene (preferred);
These include polyethylene, polypropylene, poly-α-methylstyrene, O-alkyl (eg, methyl) dextran, long-chain alkyl (eg, n-lauryl) ester of polyglutamic acid, polyphenylalanine, and the like. Note that polyamide, polyurethane, saturated polyester, etc. can also be used. To embed Fe()Tpiv PP in such hydrophobic polymers, e.g. in an inert atmosphere (e.g. nitrogen gas)
Among them, Fe()Tpiv PP, an excess amount of substituted imidazole and a hydrophobic polymer e.g. Fe Tpiv PP1
(at least 10 grams per gram) in a suitable solvent such as toluene and reduce the central iron of Fe Tpiv PP to its divalent state with a reducing agent such as sodium dithionite. Next, the solvent layer is separated, dehydrated, and freeze-dried to form Fe()Tpiv.
Hydrophobic polymer particles embedded with PP complexes are obtained. There is no particular limit to the size of these particles, but the diameter
Thicknesses of 0.2 mm or less (usually 0.01 μ or more) can be made using the above method.
こうして得られた疎水性高分子粒子を水に分散
(例えば水1当り200グラム以下)させると本発
明の酸素吸脱着剤が得られるのである。好ましく
は、該粒子を安定に水中に分散させるために、表
面濡れ性向上剤および(または)増粘剤を加える
とよい場合がある。表面濡れ性向上剤としては各
種界面活性剤があり、これは、イオン系のもので
も、また非イオン系のものでもよい。界面活性剤
の例を挙げると、ドデシル硫酸ナトリウム、ドデ
シルスルホン酸ナトリウム、ドデシル―N―サル
コシン酸ナトリウムおよびN―ラウリルグルタミ
ン酸二ナトリウムのようなアニオン系界面活性
剤、セチルトリメチルアンモニウムブロミド、テ
トラデシルアンモニウムブロミドおよびドデシル
ピリミジニウムクロリドのようなカチオン系界面
活性剤、並びにパルミトイルリゾレシチン、ドデ
シル―N―ベタイン、ポリオキシエチレンアルコ
ール、ポリオキシエチレンイソアルコール、ポリ
オキシエチレンp―t―オクチルフエノール、ポ
リオキシエチレンノニルフエノール、脂肪酸のポ
リオキシエチレンエステル、ポリオキシエチレン
ソルビツトエステルおよびポリオキシエチレンノ
ニルフエノールエーテルのような非イオン系界面
活性剤である。これらはいずれも市販されてい
る。用いる界面活性剤の量に特に制限はない。一
般に、疎水性高分子粒子重量の1〜100%で充分
である。 When the hydrophobic polymer particles thus obtained are dispersed in water (for example, 200 grams or less per water), the oxygen adsorbing/desorbing agent of the present invention can be obtained. Preferably, a surface wettability improver and/or a thickener may be added in order to stably disperse the particles in water. There are various surfactants as surface wettability improvers, which may be ionic or nonionic. Examples of surfactants include anionic surfactants such as sodium dodecyl sulfate, sodium dodecyl sulfonate, sodium dodecyl-N-sarcosinate and disodium N-laurylglutamate, cetyltrimethylammonium bromide, tetradecylammonium bromide. and cationic surfactants such as dodecylpyrimidinium chloride, as well as palmitoyl lysolecithin, dodecyl-N-betaine, polyoxyethylene alcohol, polyoxyethylene isoalcohol, polyoxyethylene p-t-octylphenol, polyoxyethylene nonyl Nonionic surfactants such as phenols, polyoxyethylene esters of fatty acids, polyoxyethylene sorbit esters, and polyoxyethylene nonylphenol ethers. All of these are commercially available. There are no particular limitations on the amount of surfactant used. Generally, 1 to 100% of the weight of the hydrophobic polymer particles is sufficient.
増粘剤は、分散液の粘度を増加させ比重の軽い
疎水性高分子粒子を分散液系中に保持する作用を
なす。この増粘剤としては水溶性高分子であれば
どのようなものであつてもよく、具体例を挙げれ
ば、カルボキシメチルセルロースのナトリウム
塩、デキストラン、ヒドロキシエチルスターチ、
ポリエチレングリコール、ポリビニルアルコー
ル、ポリビニルピロリドン、ヒアルロン酸、ポリ
ガラクツロン酸、ムコ多糖類などである。 The thickener has the function of increasing the viscosity of the dispersion and retaining hydrophobic polymer particles with a light specific gravity in the dispersion system. The thickener may be any water-soluble polymer; specific examples include sodium salt of carboxymethyl cellulose, dextran, hydroxyethyl starch,
These include polyethylene glycol, polyvinyl alcohol, polyvinylpyrrolidone, hyaluronic acid, polygalacturonic acid, and mucopolysaccharides.
この発明に従つて疎水性高分子粒子内に埋め込
まれたFe()Tpiv PPは可逆的酸素吸脱着機能
を安定に発揮し、室温下、水の共存下でも容易に
酸素錯体を形成する。すなわち、この発明の酸素
吸脱着剤は室温下、水の共存下でも動作し得る優
れた酸素運搬作用を示す。 According to this invention, Fe()Tpiv PP embedded in hydrophobic polymer particles stably exhibits a reversible oxygen adsorption/desorption function and easily forms an oxygen complex even at room temperature and in the presence of water. That is, the oxygen adsorbing and desorbing agent of the present invention exhibits an excellent oxygen transporting action that can operate at room temperature and in the coexistence of water.
以下、この発明の実施例を記す。 Examples of this invention will be described below.
実施例 1
5,10,15,20―テトラ〔α,α,α,α―
(O―ピバラミドフエニル)〕ポルフイン・鉄
()・ブロミド(以下Fe()Tpiv PP・Brと略
記する)2mg、1,2―ジメチルイミダゾール
(以下Me2Imと略記する)0.84mgおよびポリ(ス
チレン)100mgをベンゼン10mlに溶解後、窒素ガ
ス雰囲気下において亜ニチオン酸水溶液5mlを加
え充分振盪後静置し、ベンゼン層を採取し、これ
をモレキユラーシーブス3Åで脱水処理した。ベ
ンゼン溶液を凍結乾燥処理し、赤色粉末を得た。
これとは別に0.05wt/vol%のTriton X―100(ポ
リオキシエチレンノニルフエノールエーテル商品
名)と0.1wt/vol%のカルボキシメチルセルロー
スナトリウム塩(以下CMC―Naと略記する)を
含む水溶液(10ml)を繰り返し凍結脱気処理した
ものを、窒素ガス雰囲気下で上記の赤色粉末に添
加し、これを窒素ガス雰囲気下で超音波撹拌処理
を10分間行い微粒子散水を調製した。窒素ガス雰
囲気下における上記調製水の可視吸収スペクトル
を第1図のスペクトルaに示した。吸収スペクト
ルの形および吸収極大波長は561mmと530mm(肩)
であり目的とした錯体、即ち、5,10,15,20―
テトラ〔α,α,α,α―(O―ピバラミドフエ
ニル)〕ポルフイン鉄()―モノ(1,2―ジ
メチルイミダゾール)錯体を得た。Example 1 5, 10, 15, 20-tetra [α, α, α, α-
(O-pivalamidophenyl)] 2 mg of porphine iron () bromide (hereinafter abbreviated as Fe()Tpiv PP/Br), 0.84 mg of 1,2-dimethylimidazole (hereinafter abbreviated as Me 2 Im), and After dissolving 100 mg of poly(styrene) in 10 ml of benzene, 5 ml of an aqueous solution of dithionite was added in a nitrogen gas atmosphere, thoroughly shaken, and allowed to stand. A benzene layer was collected and dehydrated using 3 Å molecular sieves. The benzene solution was freeze-dried to obtain a red powder.
Separately, an aqueous solution (10 ml) containing 0.05 wt/vol% Triton was repeatedly frozen and degassed and added to the above red powder under a nitrogen gas atmosphere, and subjected to ultrasonic stirring treatment for 10 minutes under a nitrogen gas atmosphere to prepare a fine particle water spray. The visible absorption spectrum of the prepared water in a nitrogen gas atmosphere is shown in spectrum a in FIG. The shape of the absorption spectrum and the absorption maximum wavelength are 561mm and 530mm (shoulder)
and the desired complex, i.e. 5, 10, 15, 20-
A tetra[α,α,α,α-(O-pivalamidophenyl)]porphine iron()-mono(1,2-dimethylimidazole) complex was obtained.
実施例 2
実施例1において調製した微粒子分散水に室温
下で酸素ガスを吹き込み第1図のスペクトルbを
得た。この可視吸収スペクトルは、無水トルエン
中における酸素化錯体のスペクトルと一致し、鉄
()1モルに対し、酸素分子が1モルの割合で
結合した酸素錯体の生成を支持する。スペクトル
bを示す水系に、窒素ガスをバブリングすると、
初期のスペクトルaと類似のスペクトルcが得ら
れた(第2図)。スペクトルcを示す水系に、室
温下で酸素ガスを導入するとスペクトルbに類似
の酸素化錯体スペクトルdを得た。これにより、
実施例1において調製されたポルフイリン鉄
()錯体系が可逆的に酸素分子を吸脱着するこ
とを確認した。上記の酸素化錯体の安定性を可視
吸収スペクトルの経時変化より追跡した所、室温
下においてその半寿命は、1日以上であつた。Example 2 Oxygen gas was blown into the microparticle-dispersed water prepared in Example 1 at room temperature to obtain spectrum b in FIG. This visible absorption spectrum matches the spectrum of an oxygenated complex in anhydrous toluene, and supports the formation of an oxygen complex in which 1 mole of oxygen molecules are bound to 1 mole of iron (). When nitrogen gas is bubbled into an aqueous system showing spectrum b,
A spectrum c similar to the initial spectrum a was obtained (Figure 2). When oxygen gas was introduced into an aqueous system exhibiting spectrum c at room temperature, an oxygenated complex spectrum d similar to spectrum b was obtained. This results in
It was confirmed that the porphyrin iron() complex system prepared in Example 1 reversibly adsorbs and desorbs oxygen molecules. The stability of the above-mentioned oxygenated complex was tracked by the change in visible absorption spectrum over time, and its half-life was found to be more than one day at room temperature.
実施例 3
実施例1において、ポリ(スチレン)の代わり
にO―メチルデキストラン100mg、ベンゼンの代
わりにクロロホルムを用いた以外は全く同じ条
件・手法を用いFe()Tpiv PP・モノ
(Me2Im)のO―メチルデキストラン固体の微粒
子分散水を得た。この微粒子分散水を実施例2の
手法を用いて酸素錯体の生成と、可逆的酸素吸脱
着を確認した。室温における酸素錯体の安定性
は、ポリ(スチレン)系の場合よりも若干低下す
るものの、相当の安定性を示した。Example 3 Fe()Tpiv PP mono(Me 2 Im) was prepared using exactly the same conditions and methods as in Example 1 except that 100 mg of O-methyldextran was used instead of poly(styrene) and chloroform was used instead of benzene. A fine particle dispersion of solid O-methyldextran in water was obtained. Using this microparticle-dispersed water using the method of Example 2, generation of an oxygen complex and reversible oxygen adsorption/desorption were confirmed. Although the stability of the oxygen complex at room temperature was slightly lower than that of the poly(styrene) system, it showed considerable stability.
実施例 4
実施例1においてポリ(スチレン)の代わり
に、ポリ(L―グルタミン酸―n―ラウリルエス
テル)50mgを用い、更にMe2Im量を2倍量に増
やした以外は、全く同様の手法を用い微粒子分散
水を得た。この微粒子分散水を実施例2の手法を
用い検討し、酸素錯体の生成と、可逆的な酸素吸
脱着を確認した。Example 4 Exactly the same method as in Example 1 was used except that 50 mg of poly(L-glutamic acid-n-lauryl ester) was used instead of poly(styrene) and the amount of Me 2 Im was doubled. A fine particle dispersion water was obtained. This microparticle-dispersed water was examined using the method of Example 2, and the generation of oxygen complexes and reversible oxygen adsorption and desorption were confirmed.
実施例 5
実施例1において、1,2―ジメチルイミダゾ
ールのかわりに、1―トリチル―2―メチルイミ
ダゾール(Fe()ポルフイリンの50倍モル)を
用いた以外は全く同様の手法により、5,10,
15,20―テトラ〔α,α,α,α―(O―ピバラ
ミドフエニル)〕ポルフイリン鉄()―モノ
(1―トリチル―2―メチルイミダゾール)錯体
をポリスチレン粒子に埋め込んだ微粒子の分散水
溶液を得た。実施例2の手法に従い酸素の吸脱着
を確認した。室温下における酸素錯体の半寿命は
1日以上であつた。Example 5 In Example 1, 5,10 ,
Dispersion of fine particles in which 15,20-tetra[α,α,α,α-(O-pivalamidophenyl)]porphyrin iron ()-mono(1-trityl-2-methylimidazole) complex is embedded in polystyrene particles. An aqueous solution was obtained. Adsorption and desorption of oxygen was confirmed according to the method of Example 2. The half-life of the oxygen complex at room temperature was more than one day.
尚、本実施例で用いた1―トリチル―2―メチ
ルイミダゾールは、下記の様にして合成した。 Note that 1-trityl-2-methylimidazole used in this example was synthesized as follows.
2―メチルイミダゾール―銀塩4.3gr(0.023
モル)をトルエン50mlに懸濁撹拌し、塩化トリチ
ル7.0gr(0.025モル)を加え10時間加熱還流し
た。室温に戻し不溶物を別し、液を蒸発によ
り濃縮した。残渣をシリカゲルカラムにて精製し
た(200gr、CNCl3/MeOH=20/1)。目的
物をベンゼン―n―ヘプタン系から再結晶して合
成した。収量3.34gr、収率45%。マススペクト
ルM+=324。 2-Methylimidazole-silver salt 4.3gr (0.023
mol) was suspended and stirred in 50 ml of toluene, 7.0 gr (0.025 mol) of trityl chloride was added, and the mixture was heated under reflux for 10 hours. The temperature was returned to room temperature, insoluble materials were separated, and the liquid was concentrated by evaporation. The residue was purified using a silica gel column (200 gr, CNCl 3 /MeOH=20/1). The target product was synthesized by recrystallization from benzene-n-heptane system. Yield: 3.34gr, yield: 45%. Mass spectrum M + = 324.
1H―NMRスペクトル(CDCl3,TMS)δ
(ppm):7.00〜7.40(15H,m、フエニル核)、
6.86と6.76(1H,1H,d,J=1Hz、イミダゾー
ル核4位、5位)、1.67(3H,S、イミダゾール
2位の―CH3)。 1H-NMR spectrum (CDCl 3 , TMS) δ
(ppm): 7.00-7.40 (15H, m, phenyl nucleus),
6.86 and 6.76 (1H, 1H, d, J = 1 Hz, imidazole nucleus 4th and 5th positions), 1.67 (3H, S, -CH 3 at imidazole 2nd position).
IRスペクトル(KBr錠剤)Cm-1:3350,
3070,3030,1600,1520,1490,1450,1395,
1305,1240,1180,1140,1070,1035,1000,
980,910,880,865,760,750,700。 IR spectrum (KBr tablet) Cm -1 : 3350,
3070, 3030, 1600, 1520, 1490, 1450, 1395,
1305, 1240, 1180, 1140, 1070, 1035, 1000,
980, 910, 880, 865, 760, 750, 700.
第1図および第2図はこの発明の酸素吸脱着剤
の酸素化および脱酸素化状態のスペクトル図。
FIGS. 1 and 2 are spectral diagrams of the oxygenation and deoxygenation states of the oxygen adsorbent/desorbent of the present invention.
Claims (1)
の中心鉄への配位を阻害しない基、R2はアルキ
ル基、トリチル基または置換トリチル基、R3お
よびR4はそれぞれ水素または置換基)で示され
る鉄()―5,10,15,20―テトラ〔α,α,
α,α(O―ピバラミドフエニル)〕ポルフイリン
錯体を埋め込んだ疎水性高分子粒子を水系媒質に
分散させた分散液からなる酸素吸脱着剤。 2 R1がメチル基、エチル基またはプロピル基
である特許請求の範囲第1項記載の酸素吸脱着
剤。 3 疎水性高分子がポリスチレン、O―メチルデ
キストランまたはポリ(L―グルタミン酸n―ラ
ウリルエステル)である特許請求の範囲第1項ま
たは第2項記載の酸素吸脱着剤。 4 分散液が疎水性高分子粒子の濡れ性向上剤を
さらに含有する特許請求の範囲第1項ないし第3
項のいずれかに記載の酸素吸脱着剤。 5 分散液が増粘剤をさらに含有する特許請求の
範囲第1項ないし第4項のいずれかに記載の酸素
吸脱着剤。[Claims] 1 formula (Here, R 1 is a group that does not inhibit coordination to the central iron of the imidazole to which it is bonded, R 2 is an alkyl group, trityl group, or substituted trityl group, and R 3 and R 4 are each hydrogen or a substituent.) Iron ()-5, 10, 15, 20-tetra [α, α,
α,α(O-pivalamidophenyl)] An oxygen adsorbent/desorbent consisting of a dispersion liquid in which hydrophobic polymer particles embedded with a porphyrin complex are dispersed in an aqueous medium. 2. The oxygen adsorbing/desorbing agent according to claim 1, wherein R 1 is a methyl group, an ethyl group, or a propyl group. 3. The oxygen adsorbing/desorbing agent according to claim 1 or 2, wherein the hydrophobic polymer is polystyrene, O-methyldextran, or poly(L-glutamic acid n-lauryl ester). 4. Claims 1 to 3, wherein the dispersion further contains a wettability improver for hydrophobic polymer particles.
The oxygen adsorbing and desorbing agent according to any of the above. 5. The oxygen adsorbing/desorbing agent according to any one of claims 1 to 4, wherein the dispersion further contains a thickener.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56107891A JPS5810515A (en) | 1981-07-10 | 1981-07-10 | Agent for adsorption and desorption of oxygen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56107891A JPS5810515A (en) | 1981-07-10 | 1981-07-10 | Agent for adsorption and desorption of oxygen |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5810515A JPS5810515A (en) | 1983-01-21 |
JPH0152054B2 true JPH0152054B2 (en) | 1989-11-07 |
Family
ID=14470688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56107891A Granted JPS5810515A (en) | 1981-07-10 | 1981-07-10 | Agent for adsorption and desorption of oxygen |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5810515A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
EP0330801A1 (en) * | 1983-02-08 | 1989-09-06 | Schering Aktiengesellschaft | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
JPS59164790A (en) * | 1983-03-09 | 1984-09-17 | Hidetoshi Tsuchida | 5,10,15-tri(alpha,alpha,alpha-(o-pivalamide)phenyl)-20-mono(alpha-(o-(2- substituted-2-methyl)propanamide)phenyl)porphyrin and oxygen adsorbent |
SE464085B (en) * | 1988-07-11 | 1991-03-04 | Plm Ab | A POLYMER COMPOSITION WITH THE ABILITY TO CONSUM OXY AND PREPARATION OF THE COMPOSITION |
-
1981
- 1981-07-10 JP JP56107891A patent/JPS5810515A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5810515A (en) | 1983-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fidelli et al. | Green and rapid mechanosynthesis of high-porosity NU-and UiO-type metal–organic frameworks | |
Ali-Moussa et al. | Synthesis and post-synthetic modification of UiO-67 type metal-organic frameworks by mechanochemistry | |
CN104918672B (en) | Metallic organic framework | |
Gu et al. | DABCO-functionalized metal–organic framework bearing a C 2h-symmetric terphenyl dicarboxylate linker | |
JPH0152054B2 (en) | ||
Moumen et al. | MOF-assisted synthesis of mesoporous zirconium phosphate for enhanced cadmium removal from water | |
EP0066884B1 (en) | Oxygen-adsorbing and desorbing agent | |
Tsuchida et al. | Self-assembled lipidporphyrin bilayer vesicles. Microstructure and dioxygen binding in aqueous medium | |
JP3816767B2 (en) | Porphyrin metal complex and oxygen infusion containing it | |
US4530794A (en) | Iron-tetraphenylporphine complex having phosphocholine group | |
JPS635011B2 (en) | ||
JPS59179128A (en) | Oxygen adsorbing and desorbing agent | |
JPS5925766B2 (en) | Surfactant micelles containing iron (2) porphyrin complexes and oxygen adsorbing/desorbing agents | |
JP3455174B2 (en) | Substituted tetraphenylporphyrin compounds having a basic axial ligand | |
JPS5829787A (en) | Porphyrin having hydrophobic substituent group and its complex | |
Gumanov et al. | New sorbents based on tetraphenylporphyrin bound to silica gel for the separation of C 60 and C 70 fullerenes | |
JPS635032B2 (en) | ||
JPS58213711A (en) | Liposome including iron (2) porphyrin complex and agent to adsorb and to desorb oxygen | |
JP2002128782A (en) | Porphyrin aggregate | |
JPS5810132B2 (en) | Oxygen adsorption/desorption agent | |
JP3582994B2 (en) | Tetranaphthylporphyrin and its metal complexes | |
JP3390035B2 (en) | Porphyrin metal complexes with dialkylglycerophosphocholine groups | |
Spassov et al. | Synthesis and hydrogen adsorption in Cu-based coordination framework materials | |
CN106317127A (en) | Anthracene ring bis(triazole) isophthalic acid two-dimensional cobalt complex single crystal with hydrogen adsorption property and application | |
JP2549799B2 (en) | Catalyst for producing carbonic acid diester and method for producing carbonic acid diester using the same |